Gosselies, Belgium, 7 November 2018, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today provides a business update for the third quarter ended 30 September 2018. Thomas Lienard, Chief Executive Officer of Bone Therapeutics, commented: “The third quarter was a period
November 07, 2018 HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced the issuance of new patents in Hong Kong and Europe. The company’s industry leading intellectual property in spine treatments now includes 35 U.S. and foreign patents issued with 41 patents
November 07, 2018 VISTA, Calif.--(BUSINESS WIRE)--DJO®, a leading provider of medical technologies designed to get and keep people moving, announced the partnership with SirenMD, becoming the exclusive sales representative for SirenMD’s sports team market. SirenMD is a workplace collaboration platform designed to increase the quality, efficiency, and timeliness of medical decisions by facilitating coordinated communication between
Dublin, Nov. 07, 2018 (GLOBE NEWSWIRE) -- The "Surgical Navigation Systems Market Size, Share & Trends Analysis Report By End Use (Ambulatory Surgical Centers, Hospitals), By Technology, By Application (Neurology, ENT), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering. The global surgical navigation systems market size is expected to reach USD 1.25 billion by
VGI Medical is dedicated to creating the next generation of spinal implants and procedures to improve the quality of life for its patients. To do so, VGI Medical is excited to announce the completion of the renovation of its corporate headquarters in Largo, FL. To enhance the training experience for surgeons and distributors, the renovation
LEESBURG, Va., Nov. 07, 2018 (GLOBE NEWSWIRE) -- At a special meeting today, stockholders of K2M Group Holdings, Inc. (“K2M” or the “Company”) (NASDAQ: KTWO) approved the adoption of the Agreement and Plan of Merger (the “Merger Agreement”), dated as of August 29, 2018, as it may be amended from time to time, by and
MARIETTA, Ga., Nov. 7, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that its Board of Directors has unanimously authorized the adoption of a limited duration shareholder rights plan (the "Rights Plan") following receipt of notification from The Nasdaq Stock Market LLC ("Nasdaq") indicating that Nasdaq
November 07, 2018 CARLSBAD, Calif.--(BUSINESS WIRE)--Spinal Elements, a Carlsbad, CA-based spine technology company, today announced FDA clearance for claims related to the macro-, micro-, and nano-surface structure of its Ti-Bond® surface coating technology. Highlighting Spinal Elements’ portfolio are a number of products featuring Ti-Bond, including the most recently introduced Lucent® XP height- and lordosis- expandable
Malvern, PA | Nov 06, 2018 Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Cios Spin, a new mobile C-arm that delivers precise 3D images for intraoperative quality assurance. By enabling surgeons to perform intraoperative corrections based on 3D images and confirm their results, the Cios Spin can help surgeons work with
CARLSBAD, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended September 30, 2018. Summary Third Quarter 2018 Financial Results and Recent Accomplishments Revenue of $35.8 million, an increase of
